|
|
| Product Name: | BT11 | | Synonyms: | BT11;Methanone, 1,1'-(1,4-piperazinediyl)bis[1-[6-(1H-benzimidazol-2-yl)-2-pyridinyl]-;[4-[6-(1~{H}-benzimidazol-2-yl)pyridine-2-carbonyl]piperazin-1-yl]-[6-(1~{H}-benzimidazol-2-yl)pyridin-2-yl]methanone;BT11;BT 11;BT-11, >98%;piperazine-1,4-diylbis((6-(1H-benzo[d]imidazol-2-yl)pyridin-2-yl)methanone);Omilancor (BT-11) | | CAS: | 1912399-75-7 | | MF: | C30H24N8O2 | | MW: | 528.56 | | EINECS: | | | Product Categories: | | | Mol File: | 1912399-75-7.mol |  |
| Boiling point | 923.4±75.0 °C(Predicted) | | density | 1.424±0.06 g/cm3(Predicted) | | pka | 10.24±0.10(Predicted) |
| Biological Activity | BT11 is an orally active compound that binds to lanthionine synthetase C-like 2 (LANCL2) with a Kd value of 7.7 μM and can be used for the treatment of inflammatory bowel disease. | | in vivo | Oral administration of 8 mg/kg/day BT-11 to mice attenuates colitis. In the drug safety testing experiment in rats, oral high concentrations of BT-11 have good safety (detection concentration up to 1000 mg/kg/day). | | target |
| | BT11 Preparation Products And Raw materials |
|
|
Tag:BT11(1912399-75-7)
Related Product Information
|
|
|
According to the laws, regulations and policies related to "patent products", the sale of this product is prohibited!
ChemicalBook prompt
The patent owner or licensee of the product has not released any relevant information for the time being.
|